99 Millennium - Nineteenth Edition HEALTH AND WELLNESS new, it operates at a high volume, handling approximately 25,000 prescriptions daily, including all controlled substances. In his leadership roles, Dr. Angell oversees the dispensing and regulatory reporting of these substances, ensuring strict adherence to the complex regulations governing their use. Furthermore, he leads a specialized team dedicated to addressing controlled substance issues, ensuring the pharmacy operates within the legal framework while prioritizing patient care. Prior to his current position, he acted as the director of clinical operations at GenRx Pharmacy for five years. Adjacent to his responsibilities in pharmacy operations, Dr. Angell recently began operating as a professional practice manager for his business in 2024, stepping in after the previous director resigned. Though this role is temporary, he is dedicated to ensuring all professional practices continue to function smoothly until a new director is found. Dr. Angell became interested in pharmacy work at a formative age while working at a small, familyowned pharmacy in Rhode Island that specialized in compounding and home IV infusions. The pharmacist mentored him, allowing him to assist with restocking and performing various store tasks. He ultimately earned a PharmD at the University of Connecticut in 2011. Looking ahead, Dr. Angell hopes to achieve the same level of employee satisfaction and team culture that he experienced at previous pharmacies. A s a pharmacist, Dr. Michael D. Angell strives for high quality care and employee satisfaction. Since 2023, he has served as the director and pharmacist in charge of CarelonRx Inc., a pharmacy benefit manager and subsidiary of Elevance Health, a health care services company. Despite the pharmacy being relatively MICHAEL D. ANGELL, PHARMD DIRECTOR, PHARMACIST IN CHARGE CarelonRx Phoenix, AZ
RkJQdWJsaXNoZXIy MTQ5NDA2